Insider Transactions Reported by 17 Insiders of RHYTHM PHARMACEUTICALS, INC.

Symbol
RYTM on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

RHYTHM PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Meeker President and CEO, Director $16,888,039 -$3,657,824 -18% 03 Jun 2025
Hunter C. Smith Chief Financial Officer $12,356,796 -$7,874,736 -39% 12 Aug 2025
Yann Mazabraud EVP, Head of International $2,915,485 -$5,382,716 -65% 29 Apr 2025
Pamela J. Cramer Chief Human Resources Officer $2,884,554 -$6,653,801 -70% 11 Dec 2025
Alastair Garfield Chief Scientific Officer $1,726,852 -$85,483 -4.7% 01 Jul 2025
Joseph Shulman Chief Technical Officer $1,688,708 -$6,447,834 -79% 30 Oct 2025
Jennifer Kayden Lee EVP, Head of North America $1,279,325 -$866,162 -40% 14 Feb 2025
Edward T. Mathers Director $753,105 24 Jun 2025
Linda Shapiro Manning Chief Medical Officer $563,250 09 Feb 2022
LYNN A. TETRAULT Director $412,790 24 Jun 2025
JENNIFER L. GOOD Director $412,790 24 Jun 2025
Camille L. Bedrosian Director $412,790 24 Jun 2025
CHRISTOPHE JEAN Director $412,790 24 Jun 2025
Stuart A. Arbuckle Director $412,790 24 Jun 2025
DAVID W. J. MCGIRR Director $412,790 -$4,267,494 -91% 24 Jun 2025
William T. Roberts Chief Accounting Officer $279,459 29 Mar 2023
Christopher Paul German Corporate Controller & CAO $207,791 -$644,723 -76% 12 Aug 2025

Recent Insider Transactions by Companies or Individuals for RHYTHM PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.